RYTM
Price
$56.07
Change
-$1.67 (-2.89%)
Updated
Feb 21 closing price
Capitalization
3.45B
3 days until earnings call
SPRY
Price
$11.24
Change
-$0.54 (-4.58%)
Updated
Feb 21 closing price
Capitalization
1.09B
25 days until earnings call
Ad is loading...

RYTM vs SPRY

Header iconRYTM vs SPRY Comparison
Open Charts RYTM vs SPRYBanner chart's image
Rhythm Pharmaceuticals
Price$56.07
Change-$1.67 (-2.89%)
Volume$420.18K
Capitalization3.45B
ARS Pharmaceuticals
Price$11.24
Change-$0.54 (-4.58%)
Volume$1.39M
Capitalization1.09B
RYTM vs SPRY Comparison Chart
Loading...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RYTM vs. SPRY commentary
Feb 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYTM is a Buy and SPRY is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 24, 2025
Stock price -- (RYTM: $57.55 vs. SPRY: $11.77)
Brand notoriety: RYTM and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RYTM: 83% vs. SPRY: 76%
Market capitalization -- RYTM: $3.45B vs. SPRY: $1.09B
RYTM [@Biotechnology] is valued at $3.45B. SPRY’s [@Biotechnology] market capitalization is $1.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RYTM’s FA Score shows that 1 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • RYTM’s FA Score: 1 green, 4 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, RYTM is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RYTM’s TA Score shows that 5 TA indicator(s) are bullish while SPRY’s TA Score has 3 bullish TA indicator(s).

  • RYTM’s TA Score: 5 bullish, 3 bearish.
  • SPRY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, RYTM is a better buy in the short-term than SPRY.

Price Growth

RYTM (@Biotechnology) experienced а -0.05% price change this week, while SPRY (@Biotechnology) price change was +1.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

RYTM is expected to report earnings on May 06, 2025.

SPRY is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RYTM($3.45B) has a higher market cap than SPRY($1.09B). SPRY YTD gains are higher at: 11.564 vs. RYTM (2.805). SPRY has higher annual earnings (EBITDA): -60.51M vs. RYTM (-237.01M). RYTM has more cash in the bank: 298M vs. SPRY (205M). SPRY has less debt than RYTM: SPRY (102K) vs RYTM (4.03M). RYTM has higher revenues than SPRY: RYTM (113M) vs SPRY (2.57M).
RYTMSPRYRYTM / SPRY
Capitalization3.45B1.09B316%
EBITDA-237.01M-60.51M392%
Gain YTD2.80511.56424%
P/E RatioN/AN/A-
Revenue113M2.57M4,400%
Total Cash298M205M145%
Total Debt4.03M102K3,951%
FUNDAMENTALS RATINGS
RYTM: Fundamental Ratings
RYTM
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
31
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RYTMSPRY
RSI
ODDS (%)
N/A
Bearish Trend 6 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 6 days ago
89%
Momentum
ODDS (%)
Bearish Trend 6 days ago
76%
Bearish Trend 6 days ago
83%
MACD
ODDS (%)
Bearish Trend 6 days ago
78%
Bearish Trend 6 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
80%
Bullish Trend 6 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
77%
Bearish Trend 6 days ago
85%
Advances
ODDS (%)
Bullish Trend 19 days ago
82%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
80%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
90%
View a ticker or compare two or three
Ad is loading...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

RYTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, RYTM has been loosely correlated with RCKT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RYTM jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RYTM
1D Price
Change %
RYTM100%
+1.52%
RCKT - RYTM
48%
Loosely correlated
+3.15%
KYMR - RYTM
46%
Loosely correlated
+0.68%
ERAS - RYTM
45%
Loosely correlated
-1.27%
IDYA - RYTM
45%
Loosely correlated
-2.67%
RVMD - RYTM
43%
Loosely correlated
+1.97%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with SLNO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-2.08%
SLNO - SPRY
38%
Loosely correlated
-2.24%
STRO - SPRY
38%
Loosely correlated
+4.47%
KRYS - SPRY
35%
Loosely correlated
+2.25%
RYTM - SPRY
34%
Loosely correlated
+1.52%
ACLX - SPRY
34%
Loosely correlated
-1.49%
More